Constructive Self Assertiveness Via the Internet

Problems With Self-assertiveness Clinical Trial

— R2  

Official title:

Constructive Self Assertiveness Via the Internet

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04240249
• Other study ID #: Respect
• Status: Completed
• Phase: N/A
• Start date: February 1, 2020
• Est. completion date: December 31, 2022

Study information

• Verified date: April 2024
• Source: Stockholm University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

1. constructive self-assertiveness with guidance

2. constructive self-assertiveness without guidance

3. Waitlist control

Description:

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

1. constructive self-assertiveness with guidance

2. constructive self-assertiveness without guidance

3. Waitlist control

The treatment (and wait) will be 10 weeks.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 210
• Est. completion date: December 31, 2022
• Est. primary completion date: May 16, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Human,

• At least 18 years old,

• Able to speak and read Swedish,

• Informed consent.

Exclusion Criteria:

• Severe depression (as defined by a PHQ9 score of 15 points or higher),

• If on medication the dosage has been stable for at least the past 3 months,

• No ongoing psychotherapy.

Related Conditions & MeSH terms

• Problems With Self-assertiveness

Intervention

Behavioral:
• Constructive self-assertiveness program via the internet
Participants will get one "chapter" a week to work with. All chapters are presented on web pages and include information and exercises and end with homework assignments.

Locations

Country	Name	City	State
Sweden	Department of Psychology	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Stockholm University

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Hagberg T, Manhem P, Oscarsson M, Michel F, Andersson G, Carlbring P. Efficacy of transdiagnostic cognitive-behavioral therapy for assertiveness: A randomized controlled trial. Internet Interv. 2023 May 13;32:100629. doi: 10.1016/j.invent.2023.100629. eCo — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adaptive and Aggressive Assertiveness Scale	A self-report questionnaire measuring Adaptive and Aggressive Assertiveness. Higher scores mean a worse outcome. Minimum and maximum values: 30-150.	Up to 12 months
Secondary	Patient Health Questionnaire 9-item	Depression questionnaire. Higher scores mean a worse outcome. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.	Up to 12 months
Secondary	Generalized Anxiety Disorder 7	General Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.	Up to 12 months
Secondary	Liebowitz Social Anxiety Scale , self-report	Social Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-144.	Up to 12 months
Secondary	Rathus Assertiveness Schedule	Assertiveness questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: -30 to +30.	Up to 12 months
Secondary	Well-being scale	Depression scale. Lower scores mean a worse outcome. Minimum and maximum values: 0-72.	Up to 12 months